Let's be conservative and take the low end of the sales prediction for vosaroxin, which is $400m, according to the seeking alpha article, and figure out the pps for SNSS:profit margin: 70%total profit: $400mx70%=$280m/yearPE: 20future diluted shares: 60mpredicted pps=$280m/60m x20=$93/sharepresent pps=$93/2 x50%=$23/shareYes, this stock should be trading around $23/share right now.In conclusion, this stock should be trading between $23-$35/share right now, acccording to the future vosarxin sales prediction in the Seeking Alpha article, which is $400m--$600m.
pps way undervalued!
Sentiment: Strong Buy
cheap shares, higher soon
You're a moron. Right now? This company has no approved drugs, no revenue, no nothing. To say something as stupid as you just did makes you look like a fool. There is no 400m until years after drug approval if then. Get lost rookie.
snowjoe10: read my other post "$600m revenue means SNSS=$140!" and give me an apology. I just did not explain my calculations here like I did in that post.
Shorties of this stock are real morons and will get killed soon.
It's Tweedledumb and Tweedledumber.lollol